Empagliflozin for New On-set Heart Failure Study Regardless of Ejection Fraction
Clinical trial NCT05556044 · UNKNOWN
Trial details
- NCT number
- NCT05556044
- Sponsor
- Chinese University of Hong Kong
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-27
- Primary completion
- 2024-02-28
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.